Skip to content
OpenCapital
Get started

Indaptus Therapeutics, Inc. INDP Q1 2026 earnings

Reported May 15, 2026 · Before market open

Diluted EPS-$0.23Beat by $1.64
EPS estimate-$1.87

Next report

Aug 17, 2026 (in a month)
EPS estimate-$1.57

Versus estimates

Diluted EPS

Q1 2026-$0.23Beat by $1.64
Q4 2025-$3.10Beat by $1.26Q3 2025-$2.98Beat by $1.19Q2 2025-$9.09Beat by $0.15Q1 2025-$8.96Beat by $2.52Q4 2024-$0.38Beat by $0.03

Ask the moment Indaptus Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Indaptus Therapeutics, Inc. report Q1 2026 earnings?
Indaptus Therapeutics, Inc. (INDP) reported Q1 2026 earnings on May 15, 2026 before market open.
What were Indaptus Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Indaptus Therapeutics, Inc. reported diluted EPS of $-0.23 for Q1 2026.
Did Indaptus Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-1.87 by $1.64.
How did Indaptus Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 97.4% from $-8.96.
Where can I find Indaptus Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-023344) and the 10-Q periodic report (0001493152-26-023362) directly on SEC EDGAR. The filing index links above go to sec.gov.